NCT02229214View on ClinicalTrials.gov

Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Obesity

Interventions

DRUG

Qsymia

DRUG

Placebo

Trial Locations (1)

80228

Research Center, Lakewood

All Listed Sponsors

lead

VIVUS LLC

INDUSTRY

NCT02229214 - Effect of VI-0521 (Qsymia®) on Glomerular Filtration Rate (GFR) in Overweight or Obese Healthy Subjects | Biotech Hunter | Biotech Hunter